2026.07.07
What scientific rationale and supporting evidence are required to substantiate the classification of a genetic alteration as a driver mutation in the development of Anti-cancer Drugs ?
Introduction to PMDA’s Early Consideration on Driver Mutations According to the Early Consideration docu […]